Clinical Trial Update: Contrast Enhanced Ultrasound for Evaluation of Reflux Nephropathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating contrast-enhanced ultrasound for the assessment of reflux nephropathy has completed; results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Tract Infection
• Vesicoureteral Reflux

Snippet

Sponsor: University of Tennessee | Conditions: Urinary Tract Infection, Vesicoureteral Reflux | Phase 2 | Status: COMPLETED | Results posted: 2018-04-04